Are you someone living with Parkinson's disease? If so, you are aware that in addition to symptoms affecting movement, people with Parkinson's disease also experience non-motor symptoms such as problems with mood and motivation which can be difficult to treat. If you have been living with Parkinson's disease for at least 5 years and take medication for Parkinson's disease, you may be eligible to participate in a research study aimed at treating low motivation with a form of non-invasive brain stimulation called transcranial magnetic stimulation (TMS).
Examine the validity and reliability of UTRS in the assessment of essential tremor (ET) and Parkinson tremor.
We are looking for kids, ages 8-18 and their caregivers to join us for a research study to learn new techniques to deal with emotional dysregulation and behavior intervention. This study will includes one in person visit, and all other remaining visits and groups to occur within the comfort of your own home!
Are you between 18 and 45 years of age and diagnosed with multiple sclerosis, without MS relapses within the past year? Are you currently prescribed with MS medication? If so, you may be able to participate in a research study examining whether a switch to a high-efficacy medication- Ofatumumab, would work better for you than your current treatment.
The purpose of the current Phase 3 study is to confirm the effectiveness and safety of batoclimab in participants with generalized Myasthenia Gravis in 2 different doses of batoclimab compared to placebo.
Study is being conducted to ubderstand the effectiveness of ALXN2050 compared with placebo in the treatment of generalized MG (gMG) based on improvement in the Myasthenia Gravis Activities of Daily Living (MG-ADL) total score
Are you interested in advancing treatments in Parkinson's disease? Did you know that the non-motor symptoms of Parkinson's disease are often very disabling and can lead to poor outcomes with the disease? If you have Parkinson's disease, you may be eligible to take part in a research study to learn if we can use non-invasive brain stimulation to treat these symptoms in Parkinson's disease
Autoimmune MG is a antibody-mediated disease with 85% of patients have disease mediated by AChR or anti-MUSK antibodies. Study aims to use T-cells engineered CAR T cells that will kill targeted cells directly.
The purpose of this study is to identify and genomically-characterize individuals with genetically unexplained neurodevelopmental disorders, such as epilepsy. The overarching goal is to provide patients with improved information about the underlying genetic basis of their disorder and illuminate novel genetically-defined treatment approaches in the future.
If you have a child with MS who is between 10 and 18 years old who has experienced at least one MS episode in the last 12 months, or at least 2 episodes in the last 24 months, your child could qualify for a study testing a drug that is currently used to treat adults with MS.